Breast Cancer

Recent Breast Cancer clinical practice guidelines, published in JCO.
Includes access to additional tools and resources.

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer

To develop guideline recommendations concerning optimal neoadjuvant therapy for breast cancer.

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer

The aim of this work is to update key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer.

Management of Hereditary Breast Cancer

To develop recommendations for management of patients with breast cancer (BC) with germ line mutations in BC susceptibility genes.

Management of Male Breast Cancer

To develop recommendations concerning the management of male breast cancer.

Estrogen and Progesterone Receptor Testing in Breast Cancer

To update key recommendations of the American Society of Clinical Oncology/College of American Pathologists estrogen (ER) and progesterone receptor (PgR) testing in breast cancer guideline.

Use of Endocrine Therapy for Breast Cancer Risk Reduction

To update the ASCO guideline on pharmacologic interventions for breast cancer risk reduction and provide guidance on clinical issues that arise when deciding to use endocrine therapy for breast cancer risk reduction.

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer

To update the American Society of Clinical Oncology endorsement of the Cancer Care Ontario recommendations on the Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer

This focused update addresses the use of Oncotype DX in guiding decisions on the use of adjuvant systemic therapy for women with early-stage invasive breast cancer.
New content added regularly, don't miss out!

This site is intended for healthcare professionals in France, Germany, Italy, Japan and the United Kingdom only.

The selection of ASCO content on this site was made by the ASCO Publication and Education teams. Springer Healthcare selected the experts for interview. All content is made available solely for educational and informational purposes and personal use only.

© 2021 American Society of Clinical Oncology (ASCO®). All Rights Reserved.

This program is supported by an educational grant from Daiichi Sankyo and brought to you by Springer Healthcare | Contact Us | Privacy Policy

We'd love your feedback!

Before you go please let us have your feedback...